↓ Skip to main content

Dove Medical Press

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

Overview of attention for article published in Infection and Drug Resistance, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
17 X users

Readers on

mendeley
47 Mendeley
Title
Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
Published in
Infection and Drug Resistance, October 2019
DOI 10.2147/idr.s159952
Pubmed ID
Authors

Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro, Federico Martinón-Torres

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 28%
Student > Master 7 15%
Researcher 6 13%
Student > Ph. D. Student 4 9%
Student > Doctoral Student 2 4%
Other 1 2%
Unknown 14 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 21%
Agricultural and Biological Sciences 5 11%
Immunology and Microbiology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Medicine and Dentistry 3 6%
Other 3 6%
Unknown 19 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2021.
All research outputs
#2,738,144
of 23,752,589 outputs
Outputs from Infection and Drug Resistance
#95
of 1,802 outputs
Outputs of similar age
#57,640
of 351,804 outputs
Outputs of similar age from Infection and Drug Resistance
#3
of 76 outputs
Altmetric has tracked 23,752,589 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,802 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,804 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.